SEHK:2005Pharmaceuticals
SSY Group (SEHK:2005) Margin Compression Challenges Bullish Growth Narratives
SSY Group (SEHK:2005) has opened FY 2025 with first half revenue of HK$2.1b and basic EPS of HK$0.10, giving investors fresh numbers to weigh against a period of mixed profitability. The company has seen revenue move from HK$3.3b with EPS of HK$0.23 in the first half of FY 2024 to HK$2.4b with EPS of HK$0.13 in the second half of FY 2024, then to HK$2.1b and EPS of HK$0.10 in the latest half. This sets up a results season in which the key question is how much recent margin pressure might...